The Effect of Secretory Leukocyte Protease Inhibitor (SLPI) on Ischemia/Reperfusion Injury in Cardiac Transplantation-Reference-Cited by-同舟云学术

The Effect of Secretory Leukocyte Protease Inhibitor (SLPI) on Ischemia/Reperfusion Injury in Cardiac Transplantation

Published:2008-04 Issue:4 Volume:8 Page:773-782
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Schneeberger S.,Hautz T.,Wahl S. M.,Brandacher G.,Sucher R.,Steinmassl O.,Steinmassl P.,Wright C. D.,Obrist P.,Werner E. R.,Mark W.,Troppmair J.,Margreiter R.,Amberger A.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2008.02158.x/fullpdf

Reference34 articles.

1. Myocardial Stunning and Reperfusion Injury in Cardiac Surgery

2. Heart Transplantation–Associated Perioperative Ischemic Myocardial Injury

3. PROTECTING THE PUMP: Controlling Myocardial Inflammatory Responses

4. Prolonged Cold Ischemia in Rat Cardiac Allografts Promotes Ischemia–Reperfusion Injury and the Development of Graft Coronary Artery Disease in a Linear Fashion

5. COLD ISCHEMIC INJURY ACCELERATES THE PROGRESSION TO CHRONIC REJECTION IN A RAT CARDIAC ALLOGRAFT MODEL1

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications;Heliyon;2024-01

2. Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention;Microvascular Research;2023-09

3. Development of gelatin-silicon dioxide nanoparticles (GSNPs) encapsulating recombinant human secretory leukocyte protease inhibitor (rhSLPI) for reducing in vitro myocardial ischemia/reperfusion injury;Materials Today: Proceedings;2023-04

4. Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis;Scientific Reports;2023-01-12

5. Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion injury;Frontiers in Cardiovascular Medicine;2022-08-19